Ristocetin-induced platelet aggregation for monitoring of bleeding tendency in CLL treated with ibrutinib.

L Kazianka, C Drucker, C Skrabs, W Thomas, Thomas Melchardt (Co-author), S Struve, M Bergmann, P B Staber, E Porpaczy, C Einberger, M Heinz, A Hauswirth, M Raderer, I Pabinger, R Thalhammer, Alexander Egle (Co-author), C-M Wendtner, G Follows, G Hoermann, P QuehenbergerB Jilma, U Jaeger

Research output: Contribution to journalOriginal Articlepeer-review

32 Citations (Web of Science)
Original languageEnglish
Pages (from-to)1117-1122
JournalLEUKEMIA
Volume31
Issue number5
DOIs
Publication statusPublished - 2017

Keywords

  • CHRONIC LYMPHOCYTIC-LEUKEMIA
  • B-CELL MALIGNANCIES
  • TYROSINE KINASE INHIBITOR
  • SINGLE-AGENT IBRUTINIB
  • TARGETING BTK
  • FOLLOW-UP
  • MULTIPLATE(TM)
  • AGGREGOMETRY
  • PCI-32765
  • LYMPHOMA

Cite this